New hope against superbug pneumonia: Dual-Action antibiotic trial launches

NCT ID NCT07512596

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether a new antibiotic called polymyxin E2, given both through a vein and as a mist inhaled into the lungs, can safely cure hospital-acquired pneumonia caused by drug-resistant bacteria. About 48 adults with this serious lung infection will receive either the new treatment or a standard antibiotic. The goal is to see if the combination clears the infection better and helps patients recover.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tsinghua Changgung Hospital

    Beijing, Beijing Municipality, 102200, China

  • Chengdu Third People's Hospital

    Chengdu, Sichuan, 610031, China

  • First Affiliated Hospital of Gannan Medical University

    Ganzhou, Jiangxi, 341000, China

  • Foshan Nanhai District People's Hospital

    Foshan, Guangdong, 528200, China

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, 450003, China

  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu, 225000, China

  • Nuclear Industry 416 Hospital

    Chengdu, Sichuan, 610051, China

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, 518036, China

  • People's Hospital of Hunan Province

    Changsha, Hunan, 410005, China

  • Shanghai General Hospital

    Shanghai, Shanghai Municipality, 200080, China

  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, 200433, China

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, 610072, China

  • The Fifth Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450052, China

  • The Fifth Affiliated Hospital, Sun Yat-sen University

    Zhuhai, Guangdong, 519000, China

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, 233000, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, 400016, China

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    Xi'an, Shaanxi, 710000, China

  • The First Clinical College of Guangzhou Medical University

    Guangzhou, Guangdong, 510120, China

  • The Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450052, China

  • The Second Hospital Of Hebei Medical University

    Shijiazhuang, Hebei, 050000, China

  • The Third Hospital of Changsha

    Changsha, Hunan, 410015, China

  • Tianjin First Central Hospital

    Tianjin, Tianjin Municipality, 300191, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, 300052, China

  • Xi'an Chest Hospital

    Xi'an, Shaanxi, 710100, China

  • Xiangya Hospital of Central South University

    Changsha, Hunan, 410000, China

  • Yan'an University Xianyang Hospital

    Xianyang, Shaanxi, 712000, China

  • Zhengzhou Central Hospital

    Zhengzhou, Henan, 450007, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.